Absolutely. Unfortunately, approval is now based on a subjective opinion on wording and application processes and the FDA holds all the cards and can play them as they fit - at the expense of the SP and BOT's bottom line. It should never have come to this. For all the objective data and results the product can provide, I'm very nervous about the FDA's ability to say "yeah, nah, go again" in 6-9 month's time.
Absolutely. Unfortunately, approval is now based on a subjective...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
-0.005(2.33%) |
Mkt cap ! $330.7M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.0¢ | 21.0¢ | $376.0K | 1.749M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 839196 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 376358 | 5 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
21.5¢ |
Change
-0.005 ( 2.27 %) |
||||
| Open | High | Low | Volume | ||
| 21.5¢ | 22.0¢ | 21.3¢ | 737326 | ||
| Last updated 15.57pm 26/04/2024 ? | |||||
| BOT (ASX) Chart |